CompanyDrug

Roche’s Piasky (Crovalimab) Secures NMPA Approval for Untreated Paroxysmal Nocturnal Hemoglobinuria

CompanyDrug

Roche Secures NMPA Approval for Rozlytrek to Treat Pediatric NTRK Fusion-Positive Tumors

CompanyDeals

Akeso Biopharma to Acquire 35% Stake in AD Pharmaceuticals for RMB 267 Million

Company

AstraZeneca Reports 6% Revenue Growth in 2023, Driven by Oncology and Diabetes Drug Sales

CompanyDeals

I-Mab to Become U.S.-Based Biotech, Divesting All China Assets for Up to $80 Million

CompanyDeals

AbbVie Expands Licensing Agreement for Innovative sCAR-T Platform with Scripps Research

Company

AstraZeneca Announces $300 Million Investment in Next-Gen Cell Therapies Manufacturing in the U.S.

CompanyDrug

FDA Grants Priority Review for GSK’s Arexvy to Expand RSV Vaccine Age Range to 50-59

CompanyDrug

CMS Secures NMPA Approval for Clinical Trials of TYK2 Inhibitor CMS-D001 and GnRH Antagonist CMS-D002

CompanyDrug

Evopoint Biosciences Enrolls First Patient in Phase III Trial for Gout Drug XNW3009

CompanyDrug

ChinaGene Secures CDE Approval for ZVS101e Gene Therapy Targeting Retinitis Pigmentosa

CompanyDeals

Yantai Dongcheng Acquires Full Rights to Alfatide II, Targeting Diagnostic and Therapeutic Applications